Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

Dr. Daniel Koller talks to Wealth Briefing about the buying opportunity being created by low valuations in the biotech sector.

Biotech Sector To Take Off In 2023

Dr. Daniel Koller talks to Wealth Briefing about the buying opportunity being created by low valuations in the biotech sector.
21.03.2023 - Daniel Koller

This might also interest you

  • BB Biotech AG

    BB Biotech AG (SIX) (CHF)
    ISIN-No.: CH0038389992YTD: 23.47%Active share: 79.47Anzahl Positionen: 22
    Launch date: 16. November 1993